{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-279072","form_type":"8-K","ticker":"CADL","cik":"0001841387","company_name":"Candel Therapeutics, Inc.","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.757229+00:00","generated_at":"2026-05-16T20:32:56.807553+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Candel Q3 net loss $11.3M; cash $87M; secures $130M debt facility with Trinity Capital","bullets":["Net loss of $11.3M vs $10.6M in Q3 2024; R&D expenses $8.5M, G&A $4.7M.","Cash and equivalents $87.0M as of Sept 30, 2025; plus $50M upfront from Trinity Capital facility to fund operations into Q1 2027.","Entered $130M term loan with Trinity Capital Inc.; $50M drawn at closing, up to $80M additional subject to milestones.","BLA submission for CAN-2409 in localized prostate cancer planned Q4 2026; phase 3 NSCLC trial to start Q2 2026.","Pausing pancreatic cancer program (PDAC) unless external non-dilutive funding obtained."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-279072","json":"https://secwatch.observer/filing/0001193125-25-279072.json","markdown":"https://secwatch.observer/filing/0001193125-25-279072.md","text":"https://secwatch.observer/filing/0001193125-25-279072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841387/000119312525279072/0001193125-25-279072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841387/000119312525279072/cadl-20251113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:32:56.807553+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}